4/A

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: November 25, 2019
Period of Report: June 26, 2019
Accession Number: 0001177648-19-000041

View Document ↗ View on SEC.gov ↗